XETRA : ABL.DE

Abbott Laboratories

$91.08 EUR

$2.02 (2.27%)

Volume
1.11K
Average Volume
1.51K
Market Capitalization
$158.64B
P/E Ratio
33.15
Dividend Yield
2.41%
Price Target
Year High
$116.56
Year Low
$70.10
Day High
—
Day Low
—
Payout Ratio
$0.77
Current Ratio
$1.39
Company Overview

XETRA

Robert Ford

Medical - Devices

Healthcare

ABL.DE

115000

US

EUR

https://www.abbott.com

224 667 6100

002824100

N/A

Liquidity Metrics

0.65

1.39

1.01

0.37

0.77

Sales & Valuation

$44.33B

3.85

3.45

24.34

4.23

Profitability

$3.73

$6.52B

11.65%

16.12%

10.55%

4.91%

P/E Metrics

33.15

-0.54

-0.54

Analyst Price Target & Rating

Sell

2/5

40 Analysts

%

Financial Health Scores

3.24

5/9

$7.13B

$110.43B

$57.73B

$7.88B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Mary K. Moreland Executive Vice President of Human Resources
Scott Michael Leinenweber Senior Vice President of Licensing, Acquisitions & Ventures
Erica L. Battaglia Vice President and Chief Ethics & Compliance Officer
Lisa D. Earnhardt Executive Vice President & Group President of Medical Devices
Melissa Brotz Senior Vice President of Global Marketing & External Affairs
Philip Boudreau Chief Financial Officer & Executive Vice President of Finance
Robert Ford Executive Chairman, President & CEO
Daniel Gesua Sive Salvadori Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Michael Comilla Vice President of Investor Relations.
Elizabeth Cushman Executive Vice President, General Counsel & Secretary
Christopher J. Scoggins Executive Vice President of Diabetes Care
Sabina Ewing Senior Vice President of Business & Technology Services and Chief Information Officer
Poll Results

No votes yet today — be the first to share your view!

About Abbott Laboratories (XETRA:ABL.DE) Stock

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a wide range of health products through its subsidiaries worldwide. The company operates across four principal segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products division supplies generic pharmaceuticals addressing a diverse array of therapeutic areas, including gastrointestinal, cardiovascular, neurological, and hormonal conditions, alongside pain, fever, and inflammation management. This segment also provides anti-infective agents like clarithromycin, influenza vaccines, and products designed to regulate colon function. The Diagnostic Products division delivers a comprehensive suite of solu ... tions for laboratory and point-of-care settings. These include advanced laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion, alongside molecular diagnostic systems for detecting and measuring infectious agents via DNA/RNA analysis. The segment also offers rapid lateral flow tests, specialized molecular point-of-care tests for conditions like HIV, SARS-CoV-2, influenza, RSV, and strep A, blood testing cartridges, cardiometabolic test systems, drug and alcohol screening, and both remote patient monitoring and consumer self-testing devices. Additionally, it provides informatics and automation solutions to streamline laboratory operations. The Nutritional Products segment is dedicated to offering pediatric and adult nutritional items. Lastly, the Medical Devices segment provides cardiovascular devices, including solutions for rhythm management, electrophysiology, heart failure, vascular interventions, and structural heart defects. The segment further encompasses diabetes care products and neuromodulation devices for the treatment of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories is headquartered in North Chicago, Illinois.

Frequently Asked Questions

What is the current Abbott Laboratories (ABL.DE) stock price?

Abbott Laboratories(XETRA:ABL.DE) stock price is $91.08 in the last trading session. During the trading session, ABL.DE stock reached the peak price of $116.56 while $70.1 was the lowest point it dropped to. The percentage change in ABL.DE stock occurred in the recent session was 2.27% while the dollar amount for the price change in ABL.DE stock was $2.02.

ABL.DE's industry and sector of operation?

The XETRA listed ABL.DE is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of ABL.DE?

Mary K. Moreland | Executive Vice President of Human Resources
Scott Michael Leinenweber | Senior Vice President of Licensing, Acquisitions & Ventures
Erica L. Battaglia | Vice President and Chief Ethics & Compliance Officer
Lisa D. Earnhardt | Executive Vice President & Group President of Medical Devices
Melissa Brotz | Senior Vice President of Global Marketing & External Affairs

How many employees does ABL.DE have?

Number of ABL.DE employees currently stands at 115000. ABL.DE operates from 100 Abbott Park Road, Abbott Park, IL 60064-6400, US.

Link for ABL.DE official website?

Official Website of ABL.DE is: https://www.abbott.com

How do I contact ABL.DE?

ABL.DE could be contacted at phone #224 667 6100 and can also be accessed through its website. ABL.DE operates from 100 Abbott Park Road, Abbott Park, IL 60064-6400, US.

How many shares of ABL.DE are traded daily?

The average number of ABL.DE shares traded daily for last 3 months was 1.51K.

What is the market cap of ABL.DE currently?

The market value of ABL.DE currently stands at $158.64B with its latest stock price at $91.08